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Introduction: 
Mortality from chronic renal failure (CRF) in increasing Worldwide and is currently 
ranked 14th commonest cause of death1. Most patients die from cardiovascular 
disease, and management of cardiovascular risk is key to preventing both death and 
also decline of renal function to the point of end stage renal failure. In the UK 14% of 
men and 13% women have CRF, the majority being managed in primary care. In 
2014, NICE introduced guidance to help GPs manage patients with CRF, focussing 
on cardiovascular risk and prevention of late referral of patients likely to require renal 
replacement therapy2. 
 
Aim: 
We assessed management of cardiovascular risk and timeliness of referral in all new 
GP referrals to the renal clinic in 2012, and again in 2016, 2 years after the 
introduction of NICE CKD guidance in 2014. 
 
Methods: 
 
All new GP referrals to the Dorset Renal Service in 2012 and 2016 were analysed. 
Data were collected on patient age, CKD stage and eGFR (at referral), renal imaging 
pre-referral, BP, smoking, BMI, HbA1C (in diabetic patients), and lipid assessment.  
 
All statistical analyses were performed using IBM SPSS Statistics version 23. 
Comparison of pre- and post-NICE guidance proportions were compared using a 
Chi-squared test with a p value of less than 0.05 considered significant. 
 
Results: 
486 new GP referrals were received in 2012, and 574 in 2016 (18% increase post 
NICE CRF guideline). 
Data completion was 100% for age; renal imaging pre-referral; BP; BMI; diabetic 
status at referral; and, lipid assessment at referral. 2 patients in both cohorts did not 
have eGFR/renal stage assessments due to age (< 18 years), and 1 patient in the 
2016 cohort refused blood testing. 1 diabetic patient in the 2012 cohort did not have 
HbA1c testing. 
Change in proportion 
of: 
Pre-NICE 
(% yes) 
Post-NICE 
(% yes) 
Chi square p-value 
stage 4 and 5 patients 33.9 23.5 14.024 < 0.001 
eGFR < 20 7.9 6.1 1.206 0.272 
Ultrasound pre referral 47.0 47.5 0.025 0.875 
SBP > 140 65.6 57.3 7.483 0.006 
DBP > 90 26.3 19.0 8.100 0.004 
Cholesterol tested 82.7 88.8 8.178 0.004 
High BMI 34.8 40.8 4.102 0.043 
Diabetic 27.8 30.7 1.094 0.296 
Smoker 11.7 12.6 0.172 0.678 
 
Conclusion: 
 
GP referral of new patients to the renal clinic increased post-NICE CKD guidance. 
Fewer Stage 4 and 5 CKD patients were referred, but the number of patients with 
eGFR < 20 ml/min/m2 did not change significantly (late CKD referrals). BP control 
improved post-NICE and more patients had cholesterol levels checked. However, 
more referred patients were categorised as obese. Smoking cessation and pre-
referral renal imaging showed no significant change. 
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